Pathway Financial Advisers, LLC Mirum Pharmaceuticals, Inc. Transaction History
Pathway Financial Advisers, LLC
- $196 Billion
- Q3 2024
A detailed history of Pathway Financial Advisers, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Pathway Financial Advisers, LLC holds 87 shares of MIRM stock, worth $3,611. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87
Previous 87
-0.0%
Holding current value
$3,611
Previous $2.98 Million
14.05%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$273 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$186 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$143 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$134 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$128 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.53B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...